Molycorp, Inc. (NYSE: MCP), Veeco Instruments Inc. (NASDAQ: VECO), Volterra Semi (NASDAQ: VLTR), Encore Wire Corp. (NASDAQ: WIRE), Celldex Therapeutics Inc. (NASDAQ: CLDX) and Medicis Pharmaceuticals (NYSE: MRX) ratings and price targets.
Molycorp, Inc. (MCP) had its “Neutral” rating reiterated by JPMorgan Chase & Co. (NYSE:JPM).
Veeco Instruments Inc. (VECO) was upgraded by Zacks Investment Research from an “Underperform” rating to an “Outperform” rating.
Volterra Semi (VLTR) was upgraded by Zacks Investment Research from an “Underperform” rating to a “Neutral” rating.
Encore Wire Corp. (WIRE) was upgraded by Zacks Investment Research from a “Neutral” rating to an “Outperform” rating.
Celldex Therapeutics Inc. (CLDX) had its “Outperform” rating
reiterated by Wedbush. They have a price target of $6.00 on the firm.
Medicis Pharmaceuticals (MRX) had its “Neutral” rating reiterated by Goldman Sachs (NYSE:GS).
No comments:
Post a Comment